Background: Worldwide, 19.2% of healthcare workers (HCWs) get occupationally exposed to Human immune deficiency virus (HIV) annually, resulting in approximately 1,000 new HIV infections but the use of HIV post-exposure prophylaxis (PEP) is largely undocumented. We aimed at assessing the prevalence of ever taking PEP, completion rates and the self-reported reasons for non-completion among HCWs.Methods: In a cross-sectional study, we randomly selected and enrolled 206 HCWs from records of HCWs at a large Regional Referral Hospital between March and October 2020, which included medical staff, cleaners and medical students. Participants’ socio-demographic, medical, PEP initiation and completion information was obtained using a self-administered questionnaire. Comparison of “ever taking PEP” and completing PEP across gender, health cadre, age, religion and marital status categories of the HCWs was done using Pearson’s chi square test in STATA 15.0 software.Results: Majority of HCWs were aged above 35years (41.8%), female (54.4%) and qualified medical workers (64.6). Overall, 37.4% (95% CI: 30.9 - 44.2) reported to have ever taken PEP, of whom 72.7% (95% CI: 61.5 - 81.7) completed their mandatory 28days of treatment. Reasons for PEP non-completion were: drug side effects (81%), the source patient testing HIV negative (14.3%) and not finding reason to complete the treatment (4.7%).Conclusion: The prevalence of ever taking PEP is high, indicating a high rate of HCW occupational exposure to HIV. About a third of HCWs, majorly females, married and above 35-year-old do not complete PEP treatment, with the major reason being drug-related side effects. To avoid potential HIV sero-conversion, counselling on adverse events and sensitization of HCWs on good occupational safety and infection control measures, and dangers of PEP non-completion should be emphasized.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.